Colgate-Palmolive (NYSE:CL) Price Target Lowered to $83.00 at Barclays

Colgate-Palmolive (NYSE:CL) had its target price trimmed by Barclays from $96.00 to $83.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has an equal weight rating on the stock.

A number of other research analysts have also issued reports on CL. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Wells Fargo & Company reduced their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their target price for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. TD Cowen reduced their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Finally, UBS Group decreased their price objective on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $101.11.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $88.79 on Friday. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a fifty-two week low of $79.69 and a fifty-two week high of $109.30. The stock has a fifty day moving average of $92.27 and a two-hundred day moving average of $97.78. The company has a market capitalization of $72.55 billion, a price-to-earnings ratio of 25.44, a PEG ratio of 3.01 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.25%. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Insider Activity at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.37% of the stock is owned by insiders.

Institutional Investors Weigh In On Colgate-Palmolive

A number of large investors have recently added to or reduced their stakes in the company. Gordian Advisors LLC acquired a new position in Colgate-Palmolive in the 3rd quarter worth $602,000. Carrera Capital Advisors increased its position in shares of Colgate-Palmolive by 23.1% during the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after acquiring an additional 7,353 shares during the last quarter. Peak Financial Advisors LLC acquired a new position in shares of Colgate-Palmolive in the fourth quarter worth about $1,315,000. Vontobel Holding Ltd. boosted its holdings in Colgate-Palmolive by 224.6% in the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock valued at $82,626,000 after purchasing an additional 550,750 shares during the last quarter. Finally, Fiduciary Alliance LLC acquired a new stake in Colgate-Palmolive during the 4th quarter valued at approximately $4,066,000. 80.41% of the stock is owned by institutional investors and hedge funds.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.